| Members |
targetComponentId |
| substansallergi |
Allergic disposition |
| allergi mot sulfitbaserade konserveringsmedel |
Non-allergic hypersensitivity reaction caused by sulfite (disorder) |
| solskyddspreparatallergi |
Allergy to drug |
| allergi mot slipmedel i produkt |
Allergy to drug |
| allergi mot spårämne i intravenös nutrition |
Allergy to drug |
| allergi mot vaccin med tyfoidpolysackarid |
Allergy to typhoid vaccine |
| allergi mot helcellsvaccin mot tyfoid |
Allergy to typhoid vaccine |
| allergi mot kärlvidgande medel |
Allergy to drug |
| Allo-cortolones |
Cortolone (substance) |
| Allo-cortols |
Cortol |
| Allograft |
Allograft |
| ersättning av fyra eller fler koronarartärer med allograft |
Allograft bypass of four or more coronary arteries (procedure) |
| ersättning av en koronarartär med allograft |
Allograft bypass of one coronary artery (procedure) |
| ersättning av tre koronarartärer med allograft |
Allograft bypass of three coronary arteries (procedure) |
| ersättning av två koronarartärer med allograft |
Allograft bypass of two coronary arteries (procedure) |
| Allograft to organ NOC |
Allogeneic transplantation |
| Alloreplacement of organ NOC |
Allogeneic transplantation |
| Almoor-operation |
Drainage of petrous apex of mastoid |
| Alopex lagopus |
Vulpes lagopus (organism) |
| alfaamylasspecifikt extrakt |
Product containing alpha-amylase (medicinal product) |
| alfa-1-antitrypsin |
Human alpha1 proteinase inhibitor-containing product |
| Alphaherpesvirus group |
Subfamily Alphaherpesvirinae (organism) |
| alprostadil 10,16 mikrogram/ml, lösning |
Product containing precisely alprostadil 10 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| alprostadil 20,2 mikrogram/ml, lösning |
Alprostadil 20 microgram/mL solution for injection |
| alprostadil 40 mikrogram, cylinderampull, för injektion, upptrappningsförpackning |
Alprostadil only product in parenteral dose form |
| alprostadil 40 mikrogram, pulver och vätska till injektionslösning, cylinderampull |
Alprostadil only product in parenteral dose form |
| alprostadil 40 mikrogram, pulver till injektionsvätska, lösning, cylinderampull |
Alprostadil only product in parenteral dose form |
| alprostadil 500 mikrogram/ml, infusionskoncentrat, ampull 1 ml |
Alprostadil 500 microgram/mL solution for injection |
| Alteration in cardiac output: decreased |
Decreased cardiac output |
| aluminiumacetat 13 %, örondroppar |
Product containing precisely aluminium acetate 130 milligram/1 milliliter conventional release ear solution (clinical drug) |
| aluminiumacetat 8 %, örondroppar |
Product containing precisely aluminium acetate 80 milligram/1 milliliter conventional release ear solution (clinical drug) |
| Aluminum hydroxide (in vaccine) |
Aluminium hydroxide |
| aluminiumbaserat antacidum |
Aluminium compound |
| Alverine citrate+sterculia |
Alverine- and Sterculia gum-containing product |
| Amantadine hydrochloride [anti viral] |
Product containing amantadine (medicinal product) |
| Amantidine hydrochloride [parkinsons] |
Product containing amantadine (medicinal product) |
| Amato body |
Döhle body |
| Amazona ochrocephala auropalli |
Amazona auropalliata (organism) |
| tvetydigt begrepp |
Ambiguous |
| hudgranulom orsakat av amöba |
Amoeboma of skin |
| Amebic infection of other sites |
Amebic infection |
| justerad rapport |
Amended report (record artifact) |
| AJCC (American Joint Committee on Cancer) |
American Joint Committee on Cancer allowable value |
| tetrakain 4 %, gel + förband |
Product containing only tetracaine (medicinal product) |
| tetrakain 4 %, gel + ockluderande förband |
Product containing only tetracaine (medicinal product) |
| tetrakainhydroklorid 0,5 %, ögondroppar |
Tetracaine hydrochloride 5 mg/mL eye solution |
| tetrakainhydroklorid 0,5 %, ögondroppar för engångsbruk |
Tetracaine hydrochloride 5 mg/mL eye solution |
| tetrakainhydroklorid 1 %, ögondroppar |
Tetracaine hydrochloride 10 mg/mL eye solution |
| tetrakainhydroklorid 1 %, ögondroppar för engångsbruk |
Tetracaine hydrochloride 10 mg/mL eye solution |
| tetrakainhydroklorid 2 %, ögondroppar |
Product containing precisely tetracaine hydrochloride 20 milligram/1 milliliter conventional release eye solution (clinical drug) |
| amfetamin, icke läkemedel |
Amfetamine |
| amfetaminsulfat, icke läkemedel |
Amfetamine sulfate (substance) |
| Amidinotransferase |
Amidinotransferase |
| amikacin 500 mg/100 ml, infusionsvätska, lösning |
Amikacin only product in parenteral dose form |
| amikacin 500 mg/100 ml, infusion |
Amikacin only product in parenteral dose form |
| Amiloride hydrochloride |
Product containing amiloride (medicinal product) |
| Amiloride hydrochloride |
Product containing amiloride (medicinal product) |
| Amiloride hydrochloride+bumetanide |
Product containing amiloride and bumetanide (medicinal product) |
| Amino acid injection |
Amino acid |
| aminosyror 20 %, injektionsvätska, lösning |
Product containing amino acid (product) |
| aminosyror 6 %, lösning |
Product containing amino acid (product) |
| aminosyror 6,9 %, injektionsvätska, lösning |
Product containing amino acid (product) |
| aminosyror 8 %, injektionsvätska, lösning |
Product containing amino acid (product) |
| aminosyror 8,5 %, injektionsvätska, lösning |
Product containing amino acid (product) |
| Aminoacyltransferase |
Aminoacyltransferase |
| Aminobacter niigateaensis |
Aminobacter niigataensis (organism) |
| aminokapronsyra 1,25 mg/5 ml, oral sirap |
Aminocaproic acid 250 mg/mL oral solution |
| aminokapronsyra 250 mg/ml, injektionsvätska, lösning, ampull |
Product containing only aminocaproic acid in parenteral dose form (medicinal product form) |
| överdos av aminoglykosider |
Aminoglycoside antibacterial overdose (disorder) |
| Aminophenazone - chemical |
Phenazone |
| aminofyllin 100 mg, tablett med modifierad frisättning |
Aminophylline only product in oral dose form |
| aminofyllin 100 mg, depåtablett |
Aminophylline only product in oral dose form |
| Aminophylline 225mg |
Aminophylline hydrate 225 mg prolonged-release oral tablet |
| aminofyllin 225 mg, tablett med modifierad frisättning |
Aminophylline hydrate 225 mg prolonged-release oral tablet |
| aminofyllin 25 mg/ml, injektionsvätska, lösning, ampull 10 ml |
Product containing precisely aminophylline hydrate 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| aminofyllin 25 mg/ml, injektionsvätska, lösning, ampull 10 ml |
Product containing precisely aminophylline hydrate 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| aminofyllin 25 mg/ml, injektionsvätska, lösning, förfylld spruta 10 ml |
Product containing precisely aminophylline hydrate 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| aminofyllin 350 mg, tablett med modifierad frisättning |
Aminophylline only product in oral dose form |
| aminofyllin 350 mg, depåtablett |
Aminophylline only product in oral dose form |
| Aminophylline hydrate 100mg modified-release tablets |
Aminophylline only product in oral dose form |
| Aminophylline hydrate 225mg modified-release tablet |
Aminophylline hydrate 225 mg prolonged-release oral tablet |
| Aminophylline hydrate 350mg modified-release tablet |
Aminophylline only product in oral dose form |
| Aminotransferase |
Aminotransferase |
| Amitriptyline hydrochloride + perphenazine |
Product containing amitriptyline and perphenazine (medicinal product) |
| Amitriptyline hydrochloride + perphenazine 10mg/2mg tablet |
Product containing precisely amitriptyline hydrochloride 10 milligram and perphenazine 2 milligram/1 each conventional release oral tablet (clinical drug) |
| Amitriptyline hydrochloride + perphenazine 25mg/2mg tablet |
Amitriptyline hydrochloride 25 mg and perphenazine 2 mg oral tablet |
| Amitriptyline hydrochloride + perphenazine 25mg/4mg tablet |
Product containing precisely amitriptyline hydrochloride 25 milligram and perphenazine 4 milligram/1 each conventional release oral tablet (clinical drug) |
| Amitriptyline hydrochloride + perphenazine 50mg/4mg tablet |
Product containing precisely amitriptyline hydrochloride 50 milligram and perphenazine 4 milligram/1 each conventional release oral tablet (clinical drug) |
| amitriptylinhydroklorid 10 mg, lösning |
Amitriptyline-containing product in parenteral dose form |
| Amitriptyline hydrochloride 10mg/cc |
Amitriptyline-containing product in parenteral dose form |
| Amitriptyline hydrochloride+perphenazine 10mg/4mg tablet |
Amitriptyline hydrochloride 10 mg and perphenazine 4 mg oral tablet |
| amlexanox 2 mg, mukoadhesivt plåster |
Amlexanox only product |
| amlodipinbesilat + benazeprilhydroklorid |
Product containing amlodipine and benazepril (medicinal product) |
| Amlodipine besylate 10mg |
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram/1 each conventional release oral tablet (clinical drug) |
| Amlodipine besylate 10mg tablet |
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram/1 each conventional release oral tablet (clinical drug) |
| Amlodipine besylate 2.5mg tablet |
Amlodipine (as amlodipine besilate) 2.5 mg oral tablet |
| Amlodipine besylate 5mg |
Amlodipine (as amlodipine besilate) 5 mg oral tablet |
| Amlodipine besylate 5mg tablet |
Amlodipine (as amlodipine besilate) 5 mg oral tablet |
| Ammonia-lyase |
Ammonia-lyase |
| minnesstörning orsakad av substans |
Amnestic disorder |
| Amnicator test - nitrazamine |
Measurement of pH in vaginal fluid specimen using nitrazine yellow for detection of rupture of amniotic membrane |
FHIR